The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Ambu; Lantheus Medical Imaging; OptumHealth; Pacific Edge Biotechnology
Consulting or Advisory Role - Ambu; Lantheus Medical Imaging; OptumHealth; Pacific Edge Biotechnology
Impact of PSMA-targeted PET/CT in the clinical management of men with advanced prostate cancer.
 
Matthew D Tucker
No Relationships to Disclose
 
Yu-Wei Chen
Stock and Other Ownership Interests - Biogen (I)
Consulting or Advisory Role - Deloitte
 
Hesham Abdallah Yasin
No Relationships to Disclose
 
Kristin Kathleen Ancell
No Relationships to Disclose
 
Daniel Ari Barocas
No Relationships to Disclose
 
Katy Beckermann
Consulting or Advisory Role - Aravive; Bristol-Myers Squibb; Exelixis; Seagen
Research Funding - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Sam S. Chang
Honoraria - CG Oncology; FerGene; Janssen Oncology; Merck; miR Diagnostics LLC; Urogen pharma
Consulting or Advisory Role - CG Oncology; Janssen Oncology; Merck; NantBioScience; Pfizer; Photocure; Urogen pharma; UroToday; virtuoso Surgical
Research Funding - NantCell (Inst)
 
Nancy B. Davis
Consulting or Advisory Role - Janssen Biotech
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Exelixis (Inst); Gilead Sciences (Inst); Immunomedics (Inst); Incyte (Inst); Merck (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); Roche (Inst); Seattle Genetics/Astellas (Inst)
 
Aaron Jessop
No Relationships to Disclose
 
Elizabeth Kaiser
No Relationships to Disclose
 
Austin Noah Kirschner
Research Funding - Varian Medical Systems (Inst)
 
Christien Alexandre Kluwe
No Relationships to Disclose
 
Amy Luckenbaugh
No Relationships to Disclose
 
Kelvin A. Moses
Consulting or Advisory Role - Astellas Scientific and Medical Affairs Inc
Speakers' Bureau - Astellas Medivation; Dendreon; Pfizer
 
David F. Penson
No Relationships to Disclose
 
Philip Sherer
No Relationships to Disclose
 
Woodson Smelser
No Relationships to Disclose
 
Deborah Wallace
No Relationships to Disclose
 
Kerry Schaffer
Consulting or Advisory Role - Janssen Biotech
Research Funding - Tempus (Inst)
 
Brian I. Rini
Leadership - MJH Life Sciences
Stock and Other Ownership Interests - PTC Therapeutics
Consulting or Advisory Role - 3D Medicines; Aravive; Arrowhead Pharmaceuticals; AVEO; Bristol-Myers Squibb; Corvus Pharmaceuticals; Eisai; GlaxoSmithKline; Merck; Pfizer; Shionogi; Surface Oncology; synthorx
Research Funding - Aravive (Inst); Arrowhead Pharmaceuticals (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Dragonfly Therapeutics (Inst); Exelixis (Inst); Immunomedics (Inst); Incyte (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst); Surface Oncology (Inst); Taris (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Pfizer